Insilico Medicine says non-executive directors Kan Chen, Long Shi resign effective July 15

• Insilico Medicine Cayman TopCo said non-executive directors Kan Chen and Long Shi will step down effective July 15, 2026.
• Chen will also leave the board’s nomination committee; Shi will also exit the remuneration committee.
• The departures were attributed to changes in work arrangements and other business commitments, not to operations or financial performance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260715-12245767), on July 15, 2026, and is solely responsible for the information contained therein.